Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Theriva Biologics, Inc.

NYSE: TOVX · Life Sciences · 3 alerts · CIK 894158

Share price
$0.1400Close, Nov 16
Market cap
$6.42M
Shares outstanding
45.89MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Theriva Biologics, Inc. filings on SEC EDGAR ↗

4:06 PM ET 8-K
Divestiture

Theriva Biologics Divestiture to Biossil Labs Inc.

Theriva Biologics completed the sale of its antibiotic-degrading enzyme portfolio, including SYN-004 (ribaxamase), to Biossil Labs Inc. for an upfront payment of $350,000. Theriva is eligible for up to $91 million in regulatory and sales milestones plus royalties, while Biossil assumes all future development costs and responsibilities.

Counterparty
Biossil Labs Inc.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.